Please assess the completion status of the following clinical trial:

Trial Title: Chronic Pain Risk Associated With Menstrual Period Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~All~* Reproductive age women (18-45)~For dysmenorrhea and D+COS group only:~* Participants must have had regular (22-45 day) menstrual cycles over at least a two month period preceding testing~Exclusion Criteria:~All~* presence of active pelvic or abdominal malignancies (primary or metastatic)~* active genitourinary infection in the last four weeks~* unable to read or comprehend the informed consent in English~* unwilling to undergo pelvic examination/testing~* presence of hypertension or risk for developing hypertension, and~For dysmenorrhea and D+COS group only:~* absence of regular menses (including current pregnancy, recent pregnancy, or active breast feeding) unwilling to take either cyclic or combined OCs~* unwilling to withdraw from OCs for two months prior to the sensory testing study visit.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- D+COS-no OC (Type: NO_INTERVENTION): Ten participants in the Dysmenorrhea + COS group will not receive an OC intervention. Monthly questionnaires will be completed for 1 yr. QST will be repeated at 6 months and 12 months. A yearly follow-up questionnaire will be completed for 5 years.
- D+COS-cyclic microgestin 1/20 (Type: ACTIVE_COMPARATOR): 26 participants in the Dysmenorrhea + COS group will receive cyclic OC. Monthly questionnaires will be completed for 1 yr. QST will be repeated at 6 months and 12 months. A yearly follow-up questionnaire will be completed for 5 years.
- D+COS-continuous microgestin 1/20 (Type: ACTIVE_COMPARATOR): 26 participants in the Dysmenorrhea + COS group will receive continuous OC. Monthly questionnaires will be completed for 1 yr. QST will be repeated at 6 months and 12 months. A yearly follow-up questionnaire will be completed for 5 years.
- PBS-continuous microgestin 1/20 (Type: ACTIVE_COMPARATOR): 26 participants in the Painful Bladder Syndrome group will receive continuous OC. Monthly questionnaires will be completed for 1 yr. QST will be repeated at 6 months and 12 months. A yearly follow-up questionnaire will be completed for 5 years.
- No Intervention: Pain Discovery Aim (Type: NO_INTERVENTION): 255 Reproductive-age women (18-45) will be identified and divided into 5 groups~Healthy Controls Chronic Pain (Positive Controls) Dysmenorrhea (D) Dysmenorrhea with Cross Organ Sensitization (D+COS) Painful bladder syndrome (PBS)/interstitial cystitis (IC) After a screening, dysmenorrhea with COS and PBS participants will be compared with controls. Daily Diaries will be completed for 1-3 months. During the luteal phase of the participants' menstrual cycle or a predetermined time, participants will complete aim #1 testing consisting of a battery of questionnaires, bladder sensitivity testing, quantitative sensory testing (QST), a blood draw and EEG testing. All participants will also complete a yearly follow-up questionnaire for 5 years.

Based on this trial design, predict the completion outcome and termination type (if applicable).